Sort By

  1. NCQA Comments on State Innovation Model RFI

    Last modified 01.15.2019
    ncqa.org/comment-letter/ncqa-comments-on-state-innovation-model-rfi/

    NCQA provides feedback on questions and concepts related to state-based delivery and payment reform initiatives.

  2. NCQA Comments on Proposed Medicare Advantage Rules

    Last modified 01.15.2019
    ncqa.org/comment-letter/ncqa-comments-on-proposed-medicare-advantage-rules/

    NCQA supports opioid limit and value-based insurance design proposals.

  3. NCQA Comments on RFI for PACE and P3C

    Last modified 01.15.2019
    ncqa.org/comment-letter/ncqa-comments-on-rfi-for-pace-and-p3c/

    NCQA provides feedback on RFI for new and existing models of integrated care.

  4. NCQA Responds to CMS RFI on ACA Burdens

    Last modified 01.15.2019
    ncqa.org/comment-letter/ncqa-responds-to-cms-rfi-on-aca-burdens/

    NCQA urges CMS to allow deeming for accredited Exchange plans, and to reduce clinical quality measure reporting burden by moving to well-designed & tested electronic clinical quality measures.

  5. NCQA Comments on CMMI's New Direction

    Last modified 01.15.2019
    ncqa.org/comment-letter/ncqa-comments-on-cmmis-new-direction/

    NCQA provides feedback on the CMS Request for Information regarding the Innovation Center's New Direction.

  6. NCQA Comments on Proposed 2019 ACA Exchange/Marketplace Rules

    Last modified 01.15.2019
    ncqa.org/comment-letter/ncqa-comments-on-proposed-2019-aca-exchange-marketplace-rules/

    NCQA urges CMS to rely on Exchange-specific accreditation and address disparities via stratification.

  7. NCQA Congratulates HHS Secretary Azar on his Confirmation

    Last modified 01.15.2019
    ncqa.org/comment-letter/ncqa-congratulates-hhs-secretary-azar-on-his-confirmation/

    NCQA looks forward to working with Azar on our shared goal of high-quality, efficient, affordable health care.

  8. NCQA Comments on Senate Finance Committee Opioid Inquiry

    Last modified 01.15.2019
    ncqa.org/comment-letter/ncqa-comments-on-senate-finance-committee-opioid-inquiry/

    NCQA recommends adding HEDIS opioid measures to the Medicare Advantage Star Ratings to encourage action to address the epidemic.

  9. NCQA Comments on 2019 Medicare Advantage Call Letter

    Last modified 01.15.2019
    ncqa.org/comment-letter/1447/

    NCQA supports proposed opioid limits and wider use of supplemental benefits.

  10. NCQA Comments on VA MISSION Act

    Last modified 01.15.2019
    ncqa.org/comment-letter/ncqa-comments-on-va-mission-act/

    NCQA urges the VA to use our programs and expertise to help meeting MISSION Act implementation challenges.

  11. NCQA Proposed Medicare Advantage Rule Comments

    Last modified 01.15.2019
    ncqa.org/comment-letter/ncqa-proposed-medicare-advantage-rule-comments/

    NCQA supports proposals to expand telehealth, unify D-SNP appeals and share Parts A & B data with Part D-only drug plans.